182 related articles for article (PubMed ID: 18974105)
1. Conspirators in a capital crime: co-deletion of p18INK4c and p16INK4a/p14ARF/p15INK4b in glioblastoma multiforme.
Solomon DA; Kim JS; Jean W; Waldman T
Cancer Res; 2008 Nov; 68(21):8657-60. PubMed ID: 18974105
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
[TBL] [Abstract][Full Text] [Related]
3. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
[TBL] [Abstract][Full Text] [Related]
4. Deletion of RD
Poi MJ; Knobloch TJ; Li J
DNA Repair (Amst); 2017 Sep; 57():50-55. PubMed ID: 28688373
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations of RD(INK4/ARF) enhancer in human cancer cells.
Li J; Knobloch TJ; Poi MJ; Zhang Z; Davis AT; Muscarella P; Weghorst CM
Mol Carcinog; 2014 Mar; 53(3):211-8. PubMed ID: 23065809
[TBL] [Abstract][Full Text] [Related]
6. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas.
Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G
Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of the p15 cdk inhibitor in glioblastoma multiforme.
Simon M; Köster G; Ludwig M; Mahlberg R; Rho S; Watzka M; Schramm J
Acta Neuropathol; 2001 Aug; 102(2):167-74. PubMed ID: 11563632
[TBL] [Abstract][Full Text] [Related]
8. Identification of p18 INK4c as a tumor suppressor gene in glioblastoma multiforme.
Solomon DA; Kim JS; Jenkins S; Ressom H; Huang M; Coppa N; Mabanta L; Bigner D; Yan H; Jean W; Waldman T
Cancer Res; 2008 Apr; 68(8):2564-9. PubMed ID: 18381405
[TBL] [Abstract][Full Text] [Related]
9. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
[TBL] [Abstract][Full Text] [Related]
10. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
[TBL] [Abstract][Full Text] [Related]
11. Alterations in RD(INK4/ARF) -mediated en bloc regulation of the INK4-ARF locus in human squamous cell carcinoma of the head and neck.
Poi MJ; Knobloch TJ; Sears MT; Warner BM; Uhrig LK; Weghorst CM; Li J
Mol Carcinog; 2015 Jul; 54(7):532-42. PubMed ID: 24302590
[TBL] [Abstract][Full Text] [Related]
12. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
Hutter G; Scheubner M; Zimmermann Y; Kalla J; Katzenberger T; Hübler K; Roth S; Hiddemann W; Ott G; Dreyling M
Genes Chromosomes Cancer; 2006 Feb; 45(2):203-10. PubMed ID: 16258956
[TBL] [Abstract][Full Text] [Related]
13. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
[TBL] [Abstract][Full Text] [Related]
14. Mutational analysis of genes p14ARF, p15INK4b, p16INK4a, and PTEN in human nervous system tumors.
Almeida LO; Custódio AC; Araújo JJ; Rey JA; Almeida JR; Santos MJ; Clara CA; Casartelli C
Genet Mol Res; 2008 May; 7(2):451-9. PubMed ID: 18551412
[TBL] [Abstract][Full Text] [Related]
15. Genetic status of cell cycle regulators in squamous cell carcinoma of the oesophagus: the CDKN2A (p16(INK4a) and p14(ARF) ) and p53 genes are major targets for inactivation.
Smeds J; Berggren P; Ma X; Xu Z; Hemminki K; Kumar R
Carcinogenesis; 2002 Apr; 23(4):645-55. PubMed ID: 11960918
[TBL] [Abstract][Full Text] [Related]
16. Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues.
Ramsey MR; Krishnamurthy J; Pei XH; Torrice C; Lin W; Carrasco DR; Ligon KL; Xiong Y; Sharpless NE
Cancer Res; 2007 May; 67(10):4732-41. PubMed ID: 17510401
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the p16INK4A, p15INK4B and p18INK4C genes in multiple myeloma.
Tasaka T; Berenson J; Vescio R; Hirama T; Miller CW; Nagai M; Takahara J; Koeffler HP
Br J Haematol; 1997 Jan; 96(1):98-102. PubMed ID: 9012694
[TBL] [Abstract][Full Text] [Related]
18. Deletion of the Ink4-locus (the p16ink4a, p14ARF and p15ink4b genes) predicts relapse in children with ALL treated according to the Nordic protocols NOPHO-86 and NOPHO-92.
Calero Moreno TM; Gustafsson G; Garwicz S; Grandér D; Jonmundsson GK; Frost BM; Mäkipernaa A; Rasool O; Savolainen ER; Schmiegelow K; Söderhäll S; Vettenranta K; Wesenberg F; Einhorn S; Heyman M
Leukemia; 2002 Oct; 16(10):2037-45. PubMed ID: 12357355
[TBL] [Abstract][Full Text] [Related]
19. Evidence of a role for the INK4 family of cyclin-dependent kinase inhibitors in ovarian granulosa cell tumors.
Arcellana-Panlilio MY; Egeler RM; Ujack E; Magliocco A; Stuart GC; Robbins SM; Coppes MJ
Genes Chromosomes Cancer; 2002 Oct; 35(2):176-81. PubMed ID: 12203782
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression.
Aguilo F; Zhou MM; Walsh MJ
Cancer Res; 2011 Aug; 71(16):5365-9. PubMed ID: 21828241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
